TY  - GEN
AU  - Uwai,M
AU  - Terui,Y
AU  - Mishima,Y
AU  - Tomizuka,H
AU  - Ikeda,M
AU  - Itoh,T
AU  - Mori,M
AU  - Ueda,M
AU  - Inoue,R
AU  - Yamada,M
AU  - Hayasawa,H
AU  - Horiuchi,T
AU  - Niho,Y
AU  - Matsumoto,M
AU  - Ishizaka,Y
AU  - Ikeda,K
AU  - Ozawa,K
AU  - Hatake,K
TI  - A new apoptotic pathway for the complement factor B-derived fragment Bb
SN  - 0021-9541
PY  - 2000///1030
KW  - Antibodies, Monoclonal
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Blotting, Western
KW  - Complement C3
KW  - Complement C3 Convertase, Alternative Pathway
KW  - Complement C3b
KW  - immunology
KW  - Dose-Response Relationship, Drug
KW  - Fas Ligand Protein
KW  - Gene Expression
KW  - HL-60 Cells
KW  - Humans
KW  - Integrin alphaXbeta2
KW  - genetics
KW  - Leukemia
KW  - pathology
KW  - Lymphoma
KW  - Membrane Glycoproteins
KW  - physiology
KW  - Peptide Fragments
KW  - Phorbol 12,13-Dibutyrate
KW  - RNA, Messenger
KW  - metabolism
KW  - Receptors, Complement
KW  - Receptors, Tumor Necrosis Factor
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Time Factors
KW  - Tumor Cells, Cultured
KW  - Tumor Necrosis Factor-alpha
KW  - fas Receptor
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/1097-4652(200011)185:2<280::AID-JCP13>3.0.CO;2-L
ER  -